FDAnews
www.fdanews.com/articles/198100-profound-ai-breast-cancer-solution-gets-ce-mark

ProFound AI Breast Cancer Solution Gets CE Mark

July 17, 2020

ProFound AI has received CE Mark certification for Risk, a tool used to assess breast cancer risk in women.

The supportive solution provides a two-year risk assessment of a patient’s breast cancer based on a screening mammogram that is personalized to the patient.

The tool weighs a number of risk factors, including age, breast density and mammographic features, to help improve breast screening regimens and potentially spot cancers earlier.

View today's stories